Molly Brewer, MD
Gynecologic Oncology · Farmington, CTNPI 1013989615
Payments from drug & device makers
What this record shows
This record is dominated by education: $33 of the $52 with a category attached, or 62.9%. GSK accounts for 62.9% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for gynecologic oncology clinicians in CT, where the typical reported total is $614.
Across 2 payments — averaging $26.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$33
- Tesaro, Inc.$19
Across 20 payments — averaging $6593.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$132K
What the payments were for
- Food & beverage$1937%
- Education$3363%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 1 | $33 |
| Tesaro, Inc. | 1 | $19 |
How this compares
$52 in reported general payments places this provider in the 15th percentile of 25 gynecologic oncology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 12 | $3,936 |
| YuvafemEstradiol | 11 | $1,805 |
| Estradiol | 19 | $1,706 |
| Letrozole | 18 | $336 |
| Prochlorperazine Maleate | 19 | $257 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Farmington
- Jennifer JorgensenFarmington$71
- Gulden MenderesBridgeport$35K
- Gloria HuangNew Haven$27K
- Karen NishidaStamford$26K
- Amy BrownHartford$23K
- Mitchell ClarkNew Haven$9K
- Xun ZhouNew Britain$5K
- Linus ChuangDanbury$3K
- Blair McNamaraNew Haven$1K
- Conway XuHartford$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.